THC.CSE THCBF – OTC TFHC.F
Vancouver, B.C. – (January 16, 2020)
THC BioMed Intl Ltd. (CSE: THC), (“THC” or the “Company“) announces it will shorten the offering period for and accelerate the closing of its current private placement, which is being offered existing shareholders.
Due to changes in the market, the Company has determined that it will be in the best interests of the Company and its current shareholders to close this private placement within a shorter period of time. The Company will now close this offering on January 24, 2020. Completed subscription agreements and funds must be delivered to the Company by January 23, 2020 in order to participate. If no shareholders participate, the Company may choose not to make any further announcements regarding this offering.
The details of the offering were included in a press release on January 13, 2020.
About THC
THC BioMed is a Cannabis Act Licensed Producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. THC BioMed is Canada’s largest supplier of legal Cannabis Genetics. The Company is on the leading edge of scientific research and the development of products and services related in the medical cannabis industry. Management believe THC BioMed is well-positioned to be in the forefront of this rapidly growing industry.
President and CEO:
John Miller
THC Biomed Intl Ltd.
T: 1-844-THCMEDS
E: info@thcbiomed.com
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the
adequacy or the accuracy of the contents of this release.
Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC. Forward-looking information is based on certain key expectations and assumptions made by the management of THC. In some cases, you can identify forward-looking statements by the use of words such as “will,” “may,” “would,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “could” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Although THC believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release and include that (a) The Company will now close this offering on January 24, 2020, (B) completed subscription agreements and funds must be delivered to the Company by January 23, 2020 in order to participate, and (C) THC will be in the forefront of this rapidly growing industry.
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or accuracy of the contents of this release.